NEW YORK (GenomeWeb News) – A few law firms have announced that they are investigating Monogram Biosciences' board of directors for possible breach of fiduciary duty following the firm's announcement yesterday that it has signed a definitive agreement to be acquired by Laboratory Corporation of America for around $107 million.

The law firms — Levi & Korsinsky; Brodsky & Smith; and Howard G. Smith — suggested that the price of the acquisition may not be fair to Monogram's shareholders.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.